← Eichor
Condition: Secondary Progressive Multiple Sclerosis Spms Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Secondary Progressive Multiple Sclerosis Spms

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
Phase N/A · 1 location(s) · University Hospital, Basel, Switzerland · NCT05177523A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Phase 3 · 236 location(s) · Novartis Pharmaceuticals · NCT07225504A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Phase 1 · 8 location(s) · TG Therapeutics, Inc. · NCT06680037Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Phase 1/Phase 2 · 2 location(s) · Tr1X, Inc. · NCT07477639The Effect of Rituximab on Cognitive and Hand Functions in Secondary Progressive Multiple Sclerosis
Phase 2 · 1 location(s) · Cairo University · NCT06599307
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.